Note 13 - Segment Reporting - Summarized Financial Information (Details) - USD ($)		3 Months Ended
		Mar. 31, 2026		Mar. 31, 2025	Dec. 31, 2025
Revenues		$ 313,456		$ 785,815
Cost of goods sold		599,810		886,796
Selling and marketing		360,474		237,374
General and administrative		6,208,299		3,021,091
Research and development		2,096,242		3,303,918
Depreciation and amortization		1,391,384		375,384
Gain on sale of royalty rights		(1,400,010)		0
Loss from operations		(8,942,743)		(7,038,748)
Total other income (expense), net		(440,674)		(2,055,183)
Net loss		(9,383,417)		(9,093,931)
Interest Expense		147,993		659,144
Equity method investment loss		(251,844)		41,438
Capital Expenditures		5,676,932		240,873
Acquisitions to intangible assets		0		180,000
Cash and cash equivalents		52,967,801		16,951,645	$ 16,951,645
Accounts Receivable, after Allowance for Credit Loss, Current		311,600		1,287,722	1,287,722
Derivative assets		136,114		1,960,796	1,960,796
Other current assets		819,720		457,816
Assets held for sale		22,732,293			0
Total current assets		76,967,528		20,657,979	20,657,979
Investments		56,403,592		39,505,436	39,505,436
Properties, plant and equipment, net		36,096,380		29,886,209	29,886,209
Intangible assets, net		23,962,994		24,943,388	24,943,388
Goodwill		1,507,154		1,507,154	1,507,154
Other assets		23,195,885		53,104,471
Total non-current assets		141,166,005		148,946,658	148,946,658
TOTAL ASSETS		218,133,533		169,604,637	$ 169,604,637
All Segments Except Bioleum [Member]
Revenues		313,456		785,815
Cost of goods sold		599,810		886,796
Selling and marketing		356,916		236,386
General and administrative		3,878,362		2,759,690
Research and development		56,044		1,152,113
Depreciation and amortization		126,773		127,803
Gain on sale of royalty rights		(1,400,010)
Loss from operations		(3,304,439)		(4,376,973)
Total other income (expense), net		(409,727)		(1,978,085)
Net loss		(3,714,166)		(6,355,058)
Interest Expense		87,007		573,635
Equity method investment loss		(227,844)		41,438
Capital Expenditures		5,658,199		206,822
Acquisitions to intangible assets				0
Cash and cash equivalents		49,075,856		9,758,325
Accounts Receivable, after Allowance for Credit Loss, Current		311,600		287,722
Derivative assets		136,114		1,960,796
Other current assets		577,936		265,132
Assets held for sale		22,732,293
Total current assets		72,833,799		12,271,975
Investments		55,348,221		38,426,065
Properties, plant and equipment, net		21,762,536		16,232,072
Intangible assets, net		0		0
Goodwill		0		0
Other assets		10,571,595		39,803,729
Total non-current assets		87,682,352		94,461,866
TOTAL ASSETS		160,516,151		106,733,841
Metals Segment [Member]
Revenues		275,206		748,765
Cost of goods sold		599,810		886,796
Selling and marketing		34,572		13,544
General and administrative		1,343,841		494,552
Research and development		53,964		36,627
Depreciation and amortization		67,059		62,619
Gain on sale of royalty rights		0
Loss from operations		(1,824,040)		(745,373)
Total other income (expense), net		(629)		0
Net loss		(1,824,669)		(745,373)
Interest Expense		629		0
Equity method investment loss		0		0
Capital Expenditures		5,658,199		206,822
Acquisitions to intangible assets				0
Cash and cash equivalents		38,559		183,458
Accounts Receivable, after Allowance for Credit Loss, Current		311,600		287,874
Derivative assets		0		0
Other current assets		123,791		96,180
Assets held for sale		0
Total current assets		473,950		567,512
Investments		0		0
Properties, plant and equipment, net		15,331,016		2,387,121
Intangible assets, net		0		0
Goodwill		0		0
Other assets		8,452,245		13,563,776
Total non-current assets		23,783,261		15,950,897
TOTAL ASSETS		24,257,211		16,518,409
Mining Segment [Member]
Revenues	[1]	33,750		32,250
Cost of goods sold	[1]	0		0
Selling and marketing	[1]	0		0
General and administrative	[1]	316,965		164,238
Research and development	[1]	2,080		1,441
Depreciation and amortization	[1]	40,068		45,288
Gain on sale of royalty rights		(1,400,010)
Loss from operations	[1]	1,074,647		(178,717)
Total other income (expense), net	[1]	49,172		(1,589,477)
Net loss		1,123,819	[1]	(1,768,194)
Interest Expense	[1]	722		921
Equity method investment loss	[1]	0		0
Capital Expenditures	[1]	0		0
Acquisitions to intangible assets	[1]			0
Cash and cash equivalents	[1]	69,904		149,060
Accounts Receivable, after Allowance for Credit Loss, Current	[1]	0		(152)
Derivative assets	[1]	0		0
Other current assets	[1]	15,772		1,975
Assets held for sale	[1]	22,420,250
Total current assets	[1]	22,505,926		150,883
Investments	[1]	0		0
Properties, plant and equipment, net	[1]	79,030		7,160,772
Intangible assets, net	[1]	0		0
Goodwill	[1]	0		0
Other assets	[1]	913,754		16,109,357
Total non-current assets	[1]	992,784		23,270,129
TOTAL ASSETS	[1]	23,498,710		23,421,012
Strategic Investments Segment [Member]
Revenues		0		0
Cost of goods sold		0		0
Selling and marketing		0		0
General and administrative		1,487		2,786
Research and development		0		0
Depreciation and amortization		0		0
Gain on sale of royalty rights		0
Loss from operations		(1,487)		(2,786)
Total other income (expense), net		0		31,000
Net loss		(1,487)		28,214
Interest Expense		0		0
Equity method investment loss		0		0
Capital Expenditures		0		0
Acquisitions to intangible assets				0
Cash and cash equivalents		0		0
Accounts Receivable, after Allowance for Credit Loss, Current		0		0
Derivative assets		0		0
Other current assets		0		0
Assets held for sale		0
Total current assets		0		0
Investments		55,348,221		38,426,065
Properties, plant and equipment, net		6,328,338		6,328,338
Intangible assets, net		0		0
Goodwill		0		0
Other assets		730,596		730,596
Total non-current assets		62,407,155		45,484,999
TOTAL ASSETS		62,407,155		45,484,999
Corporate Segment and Other Operating Segment [Member]
Revenues		4,500		4,800
Cost of goods sold		0		0
Selling and marketing		322,344		222,842
General and administrative		2,216,069		2,098,114
Research and development		0		1,114,045
Depreciation and amortization		19,646		19,896
Gain on sale of royalty rights		0
Loss from operations		(2,553,559)		(3,450,097)
Total other income (expense), net		(458,270)		(419,608)
Net loss		(3,011,829)		(3,869,705)
Interest Expense		85,656		572,714
Equity method investment loss		(227,844)		41,438
Capital Expenditures		0		0
Acquisitions to intangible assets				0
Cash and cash equivalents		48,967,393		9,425,807
Accounts Receivable, after Allowance for Credit Loss, Current		0		0
Derivative assets		136,114		1,960,796
Other current assets		438,373		166,977
Assets held for sale		312,043
Total current assets		49,853,923		11,553,580
Investments		0		0
Properties, plant and equipment, net		24,152		355,841
Intangible assets, net		0		0
Goodwill		0		0
Other assets		475,000		9,400,000
Total non-current assets		499,152		9,755,841
TOTAL ASSETS		50,353,075		21,309,421
Bioleum Segment [Member]
Revenues		0		0
Cost of goods sold		0		0
Selling and marketing		3,558		988
General and administrative		2,329,937		261,401
Research and development		2,040,198		2,151,805
Depreciation and amortization		1,264,611		247,581
Gain on sale of royalty rights		0
Loss from operations		(5,638,304)		(2,661,775)
Total other income (expense), net		(30,947)		(77,098)
Net loss		(5,669,251)		(2,738,873)
Interest Expense		60,986		85,509
Equity method investment loss		(24,000)		0
Capital Expenditures		18,733		34,051
Acquisitions to intangible assets				180,000
Cash and cash equivalents		3,891,945		7,193,320
Accounts Receivable, after Allowance for Credit Loss, Current		0		1,000,000
Derivative assets		0		0
Other current assets		241,784		192,684
Assets held for sale		0
Total current assets		4,133,729		8,386,004
Investments		1,055,371		1,079,371
Properties, plant and equipment, net		14,333,844		13,654,137
Intangible assets, net		23,962,994		24,943,388
Goodwill		1,507,154		1,507,154
Other assets		12,624,290		13,300,742
Total non-current assets		53,483,653		54,484,792
TOTAL ASSETS		$ 57,617,382		$ 62,870,796

[1] Mining segment - asset held for sale (see Note 6)